Inventiva (IVA) Capital Expenditures (2019 - 2025)
Inventiva (IVA) posted quarterly Capital Expenditures of -$64521.7 for Q2 2025, up 76.5% year-over-year from -$36555.4 in Q2 2024, and up 76.5% quarter-over-quarter from -$274606.3 in Q2 2024.
Inventiva (IVA) Capital Expenditures (2019 - 2025) Analysis & Trends
Inventiva's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$64521.7 for Q2 2025.
- In Q2 2025, Capital Expenditures rose 76.5% year-over-year to -$64521.7; the TTM figure through Jun 2025 stood at -$949979.4 (up 10.9% YoY), while the FY2022 annual figure was -$301993.2, down 67.08% from the prior year.
- Capital Expenditures for Q2 2025 stood at -$64521.7, up from -$274606.3 in the prior quarter.
- The five-year high for Capital Expenditures was -$49455.7 in Q1 2021, with the low at -$308858.1 in Q3 2022.
- The 4-year median for Capital Expenditures is -$180747.4 (2021), against an average of -$188726.0.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 67.08% in 2022, then surged 76.5% in 2025.
- Inventiva's Capital Expenditures stood at -$180747.4 in 2021, then slumped by 67.08% to -$301993.2 in 2022, then grew by 9.07% to -$274606.3 in 2024, then soared by 76.5% to -$64521.7 in 2025.
- Business Quant data shows IVA's Capital Expenditures at -$64521.7 in Q2 2025, -$274606.3 in Q2 2024, and -$301993.2 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -64,521.70 |
| Jun 30, 2025 | -64,521.70 |
| Jun 30, 2024 | -274,606.33 |
| Jun 30, 2024 | -274,606.33 |
| Dec 31, 2022 | -301,993.22 |
| Dec 31, 2022 | -301,993.22 |
| Sep 22, 2022 | -308,858.12 |
| Sep 22, 2022 | -308,858.12 |
| Dec 31, 2021 | -180,747.41 |
| Dec 31, 2021 | -180,747.41 |
| Jun 30, 2021 | -140,899.76 |
| Jun 30, 2021 | -140,899.76 |
| Mar 31, 2021 | -49,455.68 |
| Mar 31, 2021 | -49,455.68 |
| Dec 31, 2019 | -161,605.60 |
| Dec 31, 2019 | -161,605.60 |